key: cord-0871780-afhhmdhx
authors: Fernández-de-las-Peñas, César; Martín-Guerrero, José D.; Cancela-Cilleruelo, Ignacio; Moro-López-Menchero, Paloma; Rodríguez-Jiménez, Jorge; Pellicer-Valero, Oscar J.
title: Exploring the Trajectory Recovery Curve of the number of Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study
date: 2022-02-09
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.02.010
sha: 5d79701b737834c81880e67becb3577df877e3da
doc_id: 871780
cord_uid: afhhmdhx

Objective This multicenter study investigated the recovery curve of the number of post-COVID symptoms in previously hospitalized survivors by using an exponential decay model and mosaic plots. Methods Patients hospitalized during the first wave of the pandemic (from March 10 to May 31, 2020) due to COVID-19 from five hospitals in Madrid (Spain) were scheduled for two telephone interviews at two follow-ups with a five-month period in between and were asked about the presence of post-COVID symptoms. The total number of post-COVID symptoms was monitored. Clinical features, symptoms at hospital admission, and hospitalization data were collected from medical records. Results A total of 1,593 COVID-19 survivors were assessed 8.4 (T1) and 13.2 (T2) months after hospitalization. The mean number of post-COVID symptoms was 2.6 (SD 2.0) at T1 and 1.5 (SD 1.4) at T2. The trajectory curve showed a decrease prevalence trend. The analysis also revealed that 985 (61.8%) subjects reported a greater number (T1>T2), 549 (34.5%) equal number (T1 =T2) and 59 (3.7%) lower number (T1<T2) of post-COVID symptoms in the first (T1: 8.4 months) in comparison with the second (T2: 13.2 months) assessment. Conclusion Current trajectory analysis revealed an overall decrease in the tendency in the number of post-COVID symptoms throughout the two years after the infection.

Evidence supports that between 35% to 60% of COVID-19 survivors will experience post-COVID symptoms (Fernández-de-las-Peñas et al., 2021) . The presence of post-COVID symptoms is associated with worse quality of life (Malik et al., 2022) .

Almost 90% of studies investigating post-COVID symptoms are cross-sectional (Fernández-de-las-Peñas et al., 2021; Malik et al., 2022) . Longitudinally studies assessing symptoms at different follow-up up periods have provided heterogeneous results. Huang et al (2021) reported a decrease of most post-COVID symptoms whereas 4 Seeßle et al (2021) reported a decrease in some post-COVID symptoms but an increase in others. Understanding the longitudinal evolution of post-COVID symptoms could optimize patient care and public health outcomes.

This multicenter study presents two approaches analyzing the trajectory recovery curve of the number of post-COVID symptoms: 1) an exponential bar plot model to assess the trajectory curve of post-COVID symptoms; 2) mosaic plots to investigate the patient-to-patient changes in post-COVID symptoms during the first year after hospitalization.

The LONG-COVID-EXP-CM is a multicenter cohort study including individuals hospitalized during the first wave of the pandemic (from March 10 to May 31, 2020) in five hospitals of Madrid (Spain) due to SARS-CoV-2 infection (ICD-10 code) diagnosed by RT-PCR technique and radiological findings. From all patients hospitalized during the first wave, a sample of 400 individuals from each hospital was randomly selected by a computer software. The Ethics Committees of all involved hospitals approved the study (HCSC20/495E, HSO25112020, HUFA 20/126, HUIL/092-20, HUF/EC1517). Informed consent was obtained from all participants.

Patients were scheduled for two telephone interviews at two follow-up periods with a 5-month period in between. Patients were systematically asked about a list of post-COVID symptoms, but were free to report any additional symptom that they experienced. We pooled the total number of post-COVID symptoms. Demographic (age, gender, height, weight), clinical (medical comorbidities) and hospitalization (onset symptoms at hospital admission, days at the hospital, intensive care unit admission) data were collected from medical records. These variables were adjusted in the analyses. 

From 2,000 patients randomly selected to participate, data from 1,593 (46.4% women, age: 61±16 years) were collected at hospital admission, at T1 (mean: 8.4, range 6 to 10) and T2 (mean: 13.2, range 11 to 15) months after hospital discharge.

The mean number of post-COVID symptoms was 2.6±2.0 at T1 and 1.5±1.4 at T2. 

No conflict of interest is declared by any of the authors

Participants provided informed consent before collecting data.

No personal info of any patient is provided in the text.

The LONG-COVID-EXP-CM is supported by a grant of Comunidad de Madrid y la Unión Europea, a través del Fondo Europeo de Desarrollo Regional (FEDER),

Recursos REACT-UE del Programa Operativo de Madrid 2014-2020, financiado como parte de la respuesta de la Unión a la pandemia de COVID-19. The sponsor had no role in the design, collection, management, analysis, or interpretation of the data, draft, review, or approval of the manuscript or its content. The authors were responsible for the decision to submit the manuscript for publication, and the sponsor did not participate in this decision.

COVID-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

Interleukin-6 in Covid-19: A systematic review and meta-analysis

Prevalence of Post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis

Symptoms experienced at the acute phase of SARS-CoV-2 infection as risk factor of long-term post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study

Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL): A systematic review and meta-analysis

Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis

Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study Clin Infect Dis

ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects

Dr Fernández-de-las-Peñas and Dr. Pellicer-Valero had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: All authors. Drafting of the manuscript: All authors.Critical revision of the manuscript for important intellectual content: All authors.Statistical analysis: Dr. Martín-Guerrero. Supervision: Dr. Pellicer-Valero